Mexico

Mexico

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.28 (0.20 - 0.36) 2015 Modelled WHO
0.1 (0.10 - 0.20) 2016 Modelled Razavi-Shearer et al, 2018
0.2 (0.19 - 0.21) 2013 Modelled Schweitzer et al, 2015
0.17 (0.16 - 0.19) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.21 (0.18 - 0.23) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.21 (0.19 - 0.23) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.21 (0.19 - 0.23) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.21 (0.18 - 0.23) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.21 (0.19 - 0.23) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.19 - 0.24) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.20 - 0.25) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.23 (0.21 - 0.26) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.24 (0.21 - 0.26) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.24 (0.21 - 0.26) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.24 (0.22 - 0.26) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.24 (0.22 - 0.27) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.25 (0.23 - 0.27) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.25 (0.23 - 0.27) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.25 (0.23 - 0.28) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.26 (0.24 - 0.28) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.27 (0.25 - 0.29) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.28 (0.26 - 0.30) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.28 (0.26 - 0.31) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.28 (0.26 - 0.31) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.27 - 0.32) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.27 - 0.32) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.27 - 0.33) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.27 - 0.33) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.28 - 0.33) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.28 - 0.34) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.28 - 0.35) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.28 - 0.35) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.29 - 0.36) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.17 - 0.22) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.04 (0.03 - 0.06) 2015 Modelled WHO
0.02 (0.01 - 0.02) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.02 (0.02 - 0.03) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.03) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.03) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.03) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.02 - 0.03) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.01 - 0.02) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.01 - 0.02) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.01 - 0.02) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.10) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.08 - 0.13) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.15) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.15) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.16) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.16) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.09 - 0.16) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
137,000 (115,000 - 250,000) 2016 Modelled Razavi-Shearer et al, 2018
217,974 (195,036 - 242,139) 2019 Modelled IHME, GBD 2019 (accessed 2020)
229,649 (206,275 - 253,902) 2019 Modelled IHME, GBD 2019 (accessed 2022)
240,942 (216,004 - 266,310) 2018 Modelled IHME, GBD 2019 (accessed 2022)
243,646 (218,135 - 270,728) 2017 Modelled IHME, GBD 2019 (accessed 2022)
238,523 (214,074 - 264,082) 2016 Modelled IHME, GBD 2019 (accessed 2022)
233,831 (209,707 - 259,044) 2015 Modelled IHME, GBD 2019 (accessed 2022)
234,249 (210,186 - 259,545) 2014 Modelled IHME, GBD 2019 (accessed 2022)
239,989 (215,587 - 266,220) 2013 Modelled IHME, GBD 2019 (accessed 2022)
247,496 (221,943 - 274,901) 2012 Modelled IHME, GBD 2019 (accessed 2022)
253,302 (227,191 - 281,595) 2011 Modelled IHME, GBD 2019 (accessed 2022)
254,073 (227,446 - 282,561) 2010 Modelled IHME, GBD 2019 (accessed 2022)
252,551 (227,504 - 279,494) 2009 Modelled IHME, GBD 2019 (accessed 2022)
252,866 (229,211 - 279,027) 2008 Modelled IHME, GBD 2019 (accessed 2022)
253,819 (231,826 - 278,808) 2007 Modelled IHME, GBD 2019 (accessed 2022)
254,196 (233,767 - 278,178) 2006 Modelled IHME, GBD 2019 (accessed 2022)
252,763 (233,551 - 275,750) 2005 Modelled IHME, GBD 2019 (accessed 2022)
253,166 (234,144 - 276,095) 2004 Modelled IHME, GBD 2019 (accessed 2022)
257,917 (238,797 - 280,747) 2003 Modelled IHME, GBD 2019 (accessed 2022)
264,106 (244,967 - 288,063) 2002 Modelled IHME, GBD 2019 (accessed 2022)
268,906 (248,961 - 293,486) 2001 Modelled IHME, GBD 2019 (accessed 2022)
269,672 (249,142 - 294,678) 2000 Modelled IHME, GBD 2019 (accessed 2022)
268,289 (248,003 - 293,144) 1999 Modelled IHME, GBD 2019 (accessed 2022)
267,849 (247,504 - 293,180) 1998 Modelled IHME, GBD 2019 (accessed 2022)
267,679 (246,976 - 293,659) 1997 Modelled IHME, GBD 2019 (accessed 2022)
267,077 (245,667 - 293,930) 1996 Modelled IHME, GBD 2019 (accessed 2022)
265,352 (242,936 - 292,612) 1995 Modelled IHME, GBD 2019 (accessed 2022)
263,234 (240,359 - 290,599) 1994 Modelled IHME, GBD 2019 (accessed 2022)
261,851 (238,244 - 289,593) 1993 Modelled IHME, GBD 2019 (accessed 2022)
261,052 (236,444 - 290,169) 1992 Modelled IHME, GBD 2019 (accessed 2022)
260,700 (234,495 - 292,153) 1991 Modelled IHME, GBD 2019 (accessed 2022)
260,678 (232,542 - 292,804) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

Number of new cases of HBV

National
Download
Value Year Type Source
803 2019 Survey/reported Secretaria de Salud México: Sistema Nacional de Vigilancia Epidemiológica

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.7 (1.37 - 2.10) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.69 (1.54 - 1.85) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.54 - 1.86) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.72 (1.56 - 1.89) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.60 - 1.93) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.77 (1.61 - 1.95) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.62 - 1.95) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.63 - 1.96) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.76 (1.61 - 1.94) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.65 - 1.98) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.77 (1.62 - 1.94) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.74 (1.59 - 1.92) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.72 (1.57 - 1.89) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.60 - 1.93) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.63 - 1.95) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.60 - 1.92) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.63 - 1.96) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.56 - 1.87) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.57 (1.44 - 1.72) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.47 (1.34 - 1.62) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (1.15 - 1.39) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (1.24 - 1.49) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (1.13 - 1.37) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (1.14 - 1.39) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.19 - 1.46) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.34 (1.20 - 1.49) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.46 (1.30 - 1.62) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (1.21 - 1.51) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.39 (1.25 - 1.55) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.7 (1.37 - 2.10) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.54 (1.32 - 1.79) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
7,634 2016 Modelled WHO
1,441 (1,313 - 1,582) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1,475 (1,343 - 1,621) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,525 (1,388 - 1,677) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,585 (1,443 - 1,746) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,633 (1,489 - 1,797) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,667 (1,521 - 1,833) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,685 (1,535 - 1,849) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,734 (1,583 - 1,904) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,780 (1,626 - 1,951) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,767 (1,613 - 1,940) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,762 (1,606 - 1,938) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,768 (1,613 - 1,943) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,821 (1,661 - 2,001) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,862 (1,706 - 2,045) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,870 (1,715 - 2,056) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,856 (1,703 - 2,040) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,924 (1,762 - 2,114) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,738 (1,587 - 1,906) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,645 (1,503 - 1,807) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,533 (1,402 - 1,684) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,447 (1,319 - 1,591) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,447 (1,311 - 1,590) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,477 (1,333 - 1,625) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,560 (1,405 - 1,721) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,597 (1,431 - 1,773) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,695 (1,519 - 1,884) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,788 (1,595 - 1,993) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,634 (1,459 - 1,820) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,912 (1,637 - 2,223) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2,125 (1,714 - 2,622) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2,125 (1,714 - 2,622) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (3 - 4) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2019 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 14) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
90 2014 Survey/reported WHO/UNICEF
82 2013 Survey/reported WHO/UNICEF
90 2012 Survey/reported WHO/UNICEF
98 2011 Survey/reported WHO/UNICEF
84 2010 Survey/reported WHO/UNICEF
52 2020 Survey/reported WHO/UNICEF
50 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
56 2019 Survey/reported WHO/UNICEF
79 2020 Survey/reported WHO/UNICEF
80 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
8 (6 - 12) 2015 Survey/reported Larney S et al, 2017
Technical notes
HBV National Action Plan
HBV elimination goal
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Not Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
2005
Recommendations for HBV testing of pregnant women
Partially Adopted
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Partially Adopted
No patient co-pays for HBsAg testing
Partially Adopted
Adult HBV vaccination policy for high-risk populations
Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
HCV elimination goal
2030
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Not Adopted
System for monitoring testing and treatment
Partially Adopted
Recommendations for HCV testing of pregnant women
Adopted
Registration of originator HCV DAAs
Adopted
Registration of generic HCV DAAs
Not Adopted
Licensed point-of-care PCR testing to detect HCV
Partially Adopted
No patient co-pays for anti-HCV testing
Partially Adopted
HCV testing policy
Risk-based
National treatment guidelines exist
Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Adopted
National policy for harm reduction for persons who inject drugs
Partially Adopted
National policy for syringe exchange in federal prisons
Not Adopted
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No
Decriminalization of possession of syringes and paraphernalia
Adopted
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Public budget line for testing and treatment
Adopted

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.4 (0.30 - 0.50) 2015 Modelled Blach et al, 2017
1.1 (0.80 - 1.20) 2014 Survey/reported Gower et al, 2014
1.77 (1.41 - 2.26) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.75 (1.39 - 2.23) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.73 (1.37 - 2.20) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.71 (1.36 - 2.19) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.69 (1.35 - 2.15) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.34 - 2.15) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.34 - 2.15) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.34 - 2.16) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.33 - 2.17) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.68 (1.33 - 2.16) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.61 (1.28 - 2.05) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.46 (1.18 - 1.85) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.05 - 1.61) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.15 (0.94 - 1.42) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.89 - 1.33) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.89 - 1.32) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.88 - 1.32) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.88 - 1.32) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.87 - 1.33) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.06 (0.87 - 1.33) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.87 - 1.33) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.88 - 1.34) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.88 - 1.35) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.1 (0.90 - 1.37) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.12 (0.91 - 1.39) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.94 - 1.46) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (1 - 1.58) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (1.09 - 1.75) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.49 (1.18 - 1.94) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.64 (1.28 - 2.16) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.66 (1.32 - 2.12) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.46 (0.26 - 0.49) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.4 (1.10 - 1.60) 2014 Survey/reported Gower et al, 2014
1.4 2019 Modelled Jin et al. 2017
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
18 (9.40 - 30) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
96 (93.70 - 97.50) 2019 Modelled Granados-Garcia V et al, 2019
95.3 (93.30 - 97.30) 2005 Modelled Degenhardt L et al, 2017
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
18 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
532,000 (304,000 - 557,000) 2015 Modelled Blach et al, 2017
1,333,680 (1,043,420 - 1,748,990) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1,236,990 (976,306 - 1,603,410) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,145,740 (914,128 - 1,468,130) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,068,040 (858,720 - 1,354,530) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,013,190 (820,361 - 1,270,470) 1994 Modelled IHME, GBD 2019 (accessed 2022)
991,537 (806,803 - 1,233,050) 1995 Modelled IHME, GBD 2019 (accessed 2022)
991,018 (807,529 - 1,233,870) 1996 Modelled IHME, GBD 2019 (accessed 2022)
992,224 (809,990 - 1,236,770) 1997 Modelled IHME, GBD 2019 (accessed 2022)
996,066 (815,234 - 1,241,870) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,003,440 (822,039 - 1,250,800) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,015,210 (831,288 - 1,264,940) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,029,940 (844,438 - 1,282,020) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,045,340 (858,026 - 1,297,470) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,061,920 (872,609 - 1,314,720) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,080,470 (889,210 - 1,332,000) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,101,680 (907,733 - 1,355,970) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,181,520 (969,798 - 1,464,480) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,344,230 (1,096,080 - 1,683,380) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,539,810 (1,244,390 - 1,950,990) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,713,820 (1,372,130 - 2,195,480) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,807,930 (1,437,360 - 2,343,850) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,836,280 (1,459,730 - 2,374,690) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,856,430 (1,482,040 - 2,389,420) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,873,130 (1,497,150 - 2,401,590) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,891,830 (1,510,930 - 2,414,840) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,918,680 (1,536,300 - 2,439,430) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,959,090 (1,571,180 - 2,507,790) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2,001,820 (1,588,580 - 2,558,760) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2,041,690 (1,627,340 - 2,615,390) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2,069,340 (1,648,640 - 2,645,640) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2,083,150 (1,662,690 - 2,660,420) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
160,000 (91,800 - 168,000) 2019 Modelled Dugan et al., 2021

Number of new cases of HCV

National
Download
Value Year Type Source
2,100 2019 Survey/reported Secretaria de Salud México: Sistema Nacional de Vigilancia Epidemiológica

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
11 (9.04 - 13.50) 2019 Modelled IHME, GBD 2019 (accessed 2020)
8.31 (7.51 - 9.19) 1990 Modelled IHME, GBD 2019 (accessed 2022)
8.33 (7.53 - 9.19) 1991 Modelled IHME, GBD 2019 (accessed 2022)
8.44 (7.63 - 9.32) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8.62 (7.77 - 9.52) 1993 Modelled IHME, GBD 2019 (accessed 2022)
8.7 (7.83 - 9.58) 1994 Modelled IHME, GBD 2019 (accessed 2022)
8.73 (7.85 - 9.62) 1995 Modelled IHME, GBD 2019 (accessed 2022)
8.7 (7.87 - 9.62) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8.85 (8 - 9.79) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8.95 (8.09 - 9.92) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8.8 (7.97 - 9.76) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8.68 (7.85 - 9.62) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8.58 (7.77 - 9.50) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8.69 (7.89 - 9.61) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8.61 (7.81 - 9.52) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8.78 (7.98 - 9.71) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8.78 (7.97 - 9.73) 2005 Modelled IHME, GBD 2019 (accessed 2022)
8.62 (7.81 - 9.55) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8.61 (7.81 - 9.56) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8.95 (8.11 - 9.95) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8.9 (8.04 - 9.90) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9.1 (8.21 - 10.12) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8.83 (7.96 - 9.83) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8.91 (8.03 - 9.93) 2012 Modelled IHME, GBD 2019 (accessed 2022)
9.32 (8.40 - 10.45) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9.55 (8.54 - 10.75) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9.44 (8.46 - 10.62) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10.32 (9.25 - 11.61) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9.84 (8.77 - 11.05) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11 (9.04 - 13.50) 2019 Modelled IHME, GBD 2019 (accessed 2022)
10.62 (9.10 - 12.28) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
9,924 2016 Modelled WHO
13,737 (11,294 - 16,865) 2019 Modelled IHME, GBD 2019 (accessed 2022)
13,737 (11,294 - 16,865) 2019 Modelled IHME, GBD 2019 (accessed 2020)
13,153 (11,267 - 15,215) 2018 Modelled IHME, GBD 2019 (accessed 2022)
12,675 (11,356 - 14,259) 2017 Modelled IHME, GBD 2019 (accessed 2022)
11,968 (10,669 - 13,451) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11,506 (10,289 - 12,957) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11,263 (10,093 - 12,673) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11,012 (9,922 - 12,351) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10,412 (9,389 - 11,608) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10,210 (9,207 - 11,370) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10,187 (9,196 - 11,321) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10,294 (9,293 - 11,454) 2009 Modelled IHME, GBD 2019 (accessed 2022)
10,008 (9,071 - 11,135) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9,521 (8,632 - 10,566) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9,419 (8,533 - 10,433) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9,478 (8,605 - 10,502) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9,176 (8,327 - 10,152) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9,245 (8,395 - 10,223) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9,032 (8,198 - 9,989) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8,797 (7,965 - 9,743) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8,780 (7,945 - 9,737) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8,783 (7,957 - 9,739) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8,811 (7,960 - 9,766) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8,578 (7,762 - 9,492) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8,304 (7,509 - 9,184) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8,194 (7,369 - 9,036) 1995 Modelled IHME, GBD 2019 (accessed 2022)
8,018 (7,224 - 8,834) 1994 Modelled IHME, GBD 2019 (accessed 2022)
7,799 (7,035 - 8,618) 1993 Modelled IHME, GBD 2019 (accessed 2022)
7,496 (6,770 - 8,276) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7,256 (6,559 - 8,007) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7,102 (6,418 - 7,854) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
9 (9 - 10) 1990 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 11) 1991 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 1993 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 13) 1994 Modelled IHME, GBD 2019 (accessed 2022)
12 (11 - 13) 1995 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 14) 1996 Modelled IHME, GBD 2019 (accessed 2022)
14 (12 - 15) 1997 Modelled IHME, GBD 2019 (accessed 2022)
15 (13 - 16) 1998 Modelled IHME, GBD 2019 (accessed 2022)
16 (14 - 18) 1999 Modelled IHME, GBD 2019 (accessed 2022)
17 (16 - 19) 2001 Modelled IHME, GBD 2019 (accessed 2022)
17 (15 - 18) 2000 Modelled IHME, GBD 2019 (accessed 2022)
19 (17 - 21) 2004 Modelled IHME, GBD 2019 (accessed 2022)
18 (16 - 20) 2002 Modelled IHME, GBD 2019 (accessed 2022)
19 (17 - 20) 2003 Modelled IHME, GBD 2019 (accessed 2022)
19 (17 - 21) 2005 Modelled IHME, GBD 2019 (accessed 2022)
20 (18 - 22) 2006 Modelled IHME, GBD 2019 (accessed 2022)
20 (18 - 23) 2007 Modelled IHME, GBD 2019 (accessed 2022)
21 (19 - 23) 2008 Modelled IHME, GBD 2019 (accessed 2022)
22 (19 - 24) 2010 Modelled IHME, GBD 2019 (accessed 2022)
21 (19 - 23) 2009 Modelled IHME, GBD 2019 (accessed 2022)
22 (20 - 25) 2011 Modelled IHME, GBD 2019 (accessed 2022)
23 (20 - 25) 2012 Modelled IHME, GBD 2019 (accessed 2022)
23 (20 - 25) 2013 Modelled IHME, GBD 2019 (accessed 2022)
23 (20 - 25) 2014 Modelled IHME, GBD 2019 (accessed 2022)
23 (21 - 25) 2015 Modelled IHME, GBD 2019 (accessed 2022)
23 (21 - 26) 2016 Modelled IHME, GBD 2019 (accessed 2022)
23 (21 - 25) 2017 Modelled IHME, GBD 2019 (accessed 2022)
23 (21 - 26) 2018 Modelled IHME, GBD 2019 (accessed 2022)
24 (21 - 26) 2019 Modelled IHME, GBD 2019 (accessed 2022)
42 (37 - 46) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of tests for HCV administered

National
Download
Value Year Year Type Source
46,745 2019 Survey/reported Secretaría de Salud de Mexico (Secretary of Health)

Number of persons treated for HCV

National
Download
Value Year Type Source
6,000 2018 Survey/reported WHO, 2021
8,143 2020 Survey/reported Presentation from Dr. Kershenobich, Hep Test webinar 2020
6,500 2019 Survey/reported Secretaría de Salud de Mexico (Secretary of Health)
Showing out of
Show more
People living with HIV (PLHIV)
Download
Value Year Type Source
967 2019 Survey/reported Secretaría de Salud de Mexico (Secretary of Health)
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
8 (6 - 12) 2015 Survey/reported Larney S et al, 2017
Technical notes
HBV National Action Plan
HBV elimination goal
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Not Adopted
HepB birth dose policy
Yes
Year of birth dose introduction
2005
Recommendations for HBV testing of pregnant women
Partially Adopted
Eligible for HBV generic medicines
Licensed point-of-care PCR testing to detect HBV
Partially Adopted
No patient co-pays for HBsAg testing
Partially Adopted
Adult HBV vaccination policy for high-risk populations
Adopted
Public budget line for testing and treatment
Adopted
HCV National Action Plan
HCV elimination goal
HCV elimination goal
2030
National prevalence survey within the last 5 years
Partially Adopted
Estimates of economic burden
Not Adopted
System for monitoring testing and treatment
Partially Adopted
Recommendations for HCV testing of pregnant women
Adopted
Registration of originator HCV DAAs
Adopted
Registration of generic HCV DAAs
Not Adopted
Licensed point-of-care PCR testing to detect HCV
Partially Adopted
No patient co-pays for anti-HCV testing
Partially Adopted
HCV testing policy
Risk-based
National treatment guidelines exist
Adopted
Simplified care: Non-specialists can prescribe treatment
Adopted
Simplified care: No treatment co-pays
Adopted
No fibrosis restrictions
Adopted
No sobriety restrictions
Adopted
National policy for harm reduction for persons who inject drugs
Partially Adopted
National policy for syringe exchange in federal prisons
Not Adopted
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No
Decriminalization of possession of syringes and paraphernalia
Adopted
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Public budget line for testing and treatment
Adopted

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
2,125
2019
(1,714 - 2,622)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
13,737
2019
(11,294 - 16,865)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
50 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
8
2015
(6 - 12)
Larney S et al, 2017
Eligible for HBV generic medicines

Resources